MRNA Working Capital Ratio
29.93%Quarterly
Period ending:
MRNA FY Working Capital Ratio%
73.38%20.94%
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
MRNA working capital ratio history
Working capital as percentage of total assets. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Working Capital Ratio |
|---|---|
| 36.9347% | |
| 41.6702% | |
| 39.6722% | |
| 32.9028% | |
| 28.1446% | |
| 26.0188% | |
| 62.0156% | |
| 68.3028% | |
| 54.566% | |
| 65.2255% |
Compare working capital ratio
All MRNA financial metrics · MRNA stock overview · How to interpret financial metrics
